ARCHIVES

Clearinghouse Members Names, First Meeting Scheduled For Nov. 8-9

This article is from The Cancer Letter archive.

Vol. 02 No. 39 | September 24, 1976

Download PDF Visit The Full Archive

Related Articles

Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility

February 1, 1980

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Overwhelming 89 To 7 Vote By Senate Overturns President Reagan’s Veto Of NIH Reauthorization

November 29, 1985

In Brief: Senate Markup adds $22 Mil. To NCI Budget; Roper formally Named NCI Deputy Director

September 22, 1989

DCE Board Approves Study of Breast Cancer On Long Island

June 17, 1994